Literature DB >> 28356991

Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.

Masatsune Shibutani1, Kiyoshi Maeda1, Hisashi Nagahara1, Yasuhito Iseki1, Tetsuro Ikeya1, Kosei Hirakawa1.   

Abstract

A correlation between the lymphocyte-to-monocyte ratio (LMR) and the survival of patients with hematological malignancies has been reported previously. However, there have been few studies investigating the prognostic significance of LMR in patients with solid tumors. The aim of the present study was to evaluate the prognostic significance of preoperative LMR in patients with colorectal cancer (CRC). A total of 189 patients undergoing potentially curative surgery for CRC were enrolled. The LMR was calculated from preoperative blood samples by dividing absolute lymphocyte count by absolute monocyte count. A cut-off value of 4.8 was set based on the receiver operating characteristic curve; 116 patients were classified as high-LMR, and 73 patients classified as low-LMR. The high-LMR group exhibited significantly better relapse-free survival (P=0.0018) and overall survival (P=0.0127) rates than the low-LMR group. According to the multivariate analysis of survival, preoperative LMR was identified as an independent prognostic factor for relapse-free survival (P=0.041) and overall survival (P=0.031). Therefore, preoperative LMR is a useful prognostic marker in patients with CRC.

Entities:  

Keywords:  biomarker; colorectal cancer; inflammation; lymphocyte-to-monocyte ratio; prognosis

Year:  2016        PMID: 28356991      PMCID: PMC5351160          DOI: 10.3892/ol.2016.5487

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

2.  Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.

Authors:  Yoo-Young Lee; Chel Hun Choi; Chang Ohk Sung; In-Gu Do; SeungJae Huh; Taejong Song; Min Kyu Kim; Ha-Jeong Kim; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Gynecol Oncol       Date:  2011-10-19       Impact factor: 5.482

Review 3.  The chemokine system and cancer.

Authors:  Frances R Balkwill
Journal:  J Pathol       Date:  2011-11-23       Impact factor: 7.996

4.  Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma.

Authors:  Atsushi Sasaki; Yukio Iwashita; Kohei Shibata; Toshifuni Matsumoto; Masayuki Ohta; Seigo Kitano
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

Review 5.  Inflammation and colon cancer.

Authors:  Janos Terzić; Sergei Grivennikov; Eliad Karin; Michael Karin
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

6.  Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection.

Authors:  Koichiro Haruki; Hiroaki Shiba; Yuki Fujiwara; Kenei Furukawa; Shigeki Wakiyama; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  J Surg Oncol       Date:  2012-01-09       Impact factor: 3.454

7.  Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Kenji Sugano; Tetsuro Ikeya; Kenjiro Kimura; Ryosuke Amano; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Masaichi Ohira; Kosei Hirakawa
Journal:  Hepatogastroenterology       Date:  2014 Nov-Dec

8.  A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Anticancer Res       Date:  2013-08       Impact factor: 2.480

9.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Authors:  Isabelle Ray-Coquard; Claire Cropet; Martine Van Glabbeke; Catherine Sebban; Axel Le Cesne; Ian Judson; Olivier Tredan; Jaap Verweij; Pierre Biron; Inthidar Labidi; Jean-Paul Guastalla; Thomas Bachelot; David Perol; Sylvie Chabaud; Pancras C W Hogendoorn; Philippe Cassier; Armelle Dufresne; Jean-Yves Blay
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

Review 10.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

View more
  14 in total

1.  The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Tatsunari Fukuoka; Shinji Matsutani; Kenjiro Kimura; Ryosuke Amano; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

2.  Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study.

Authors:  Yunyun Xu; Hongjun He; Yinshan Zang; Zhe Yu; Huaixia Hu; Jiajia Cui; Wenwen Wang; Yingying Gao; Hua Wei; Zhuqing Wang
Journal:  Clin Rheumatol       Date:  2022-03-09       Impact factor: 2.980

3.  Anti-inflammatory Activity of Mesenchymal Stem Cells in λ-Carrageenan-Induced Chronic Inflammation in Rats: Reactions of the Blood System, Leukocyte-Monocyte Ratio.

Authors:  Nataliia Petryk; Oleksandr Shevchenko
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

4.  Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Suguru Hayase; Wataru Sakamoto; Hirokazu Okayama; Shotaro Fujita; Motonobu Saito; Tomoyuki Momma; Shinji Ohki; Koji Kono
Journal:  Fukushima J Med Sci       Date:  2018-07-14

5.  The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Tatsunari Fukuoka; Shigetomi Nakao; Shinji Matsutani; Kosei Hirakawa; Masaichi Ohira
Journal:  BMC Cancer       Date:  2017-06-05       Impact factor: 4.430

6.  Combined fibrinogen and neutrophil-lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma.

Authors:  Xiao Li; Bang An; Qi Zhao; Jianni Qi; Wenwen Wang; Di Zhang; Zhen Li; Chengyong Qin
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

7.  Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer.

Authors:  Yao Lu; Dao Xin; Feng Wang
Journal:  Onco Targets Ther       Date:  2019-09-20       Impact factor: 4.147

8.  Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer.

Authors:  Ying-Ying Zhang; Wan-Qing Li; Zhen-Fa Li; Xiao-Hua Guo; Shen-Kang Zhou; Aifen Lin; Wei-Hua Yan
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

9.  The platelets-neutrophils to lymphocytes ratio: a new prognostic marker in metastatic colorectal cancer.

Authors:  Joey Mercier; Ioannis A Voutsadakis
Journal:  J Gastrointest Oncol       Date:  2018-06

10.  Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer.

Authors:  Seiichi Shinji; Yoshibumi Ueda; Takeshi Yamada; Michihiro Koizumi; Yasuyuki Yokoyama; Goro Takahashi; Masahiro Hotta; Takuma Iwai; Keisuke Hara; Kohki Takeda; Mikihiro Okusa; Hayato Kan; Eiji Uchida
Journal:  Oncotarget       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.